4-122612679-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_021803.4(IL21):c.*31C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0654 in 1,400,228 control chromosomes in the GnomAD database, including 3,430 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.050 ( 277 hom., cov: 32)
Exomes 𝑓: 0.067 ( 3153 hom. )
Consequence
IL21
NM_021803.4 3_prime_UTR
NM_021803.4 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.163
Genes affected
IL21 (HGNC:6005): (interleukin 21) This gene encodes a member of the common-gamma chain family of cytokines with immunoregulatory activity. The encoded protein plays a role in both the innate and adaptive immune responses by inducing the differentiation, proliferation and activity of multiple target cells including macrophages, natural killer cells, B cells and cytotoxic T cells. Dysregulation of this gene plays a role in multiple immune-mediated diseases including lupus, psoriasis and chronic inflammatory diseases. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Dec 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 4-122612679-G-A is Benign according to our data. Variant chr4-122612679-G-A is described in ClinVar as [Benign]. Clinvar id is 1229892.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0734 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IL21 | NM_021803.4 | c.*31C>T | 3_prime_UTR_variant | 5/5 | ENST00000648588.1 | NP_068575.1 | ||
IL21 | NM_001207006.3 | c.*148C>T | 3_prime_UTR_variant | 4/4 | NP_001193935.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IL21 | ENST00000648588.1 | c.*31C>T | 3_prime_UTR_variant | 5/5 | NM_021803.4 | ENSP00000497915 | P1 | |||
IL21 | ENST00000647784.1 | n.372C>T | non_coding_transcript_exon_variant | 4/4 | ||||||
IL21 | ENST00000611104.2 | downstream_gene_variant | 1 | ENSP00000477555 |
Frequencies
GnomAD3 genomes AF: 0.0505 AC: 7671AN: 152048Hom.: 277 Cov.: 32
GnomAD3 genomes
AF:
AC:
7671
AN:
152048
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0527 AC: 13146AN: 249456Hom.: 445 AF XY: 0.0541 AC XY: 7295AN XY: 134960
GnomAD3 exomes
AF:
AC:
13146
AN:
249456
Hom.:
AF XY:
AC XY:
7295
AN XY:
134960
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0673 AC: 83934AN: 1248062Hom.: 3153 Cov.: 19 AF XY: 0.0665 AC XY: 42064AN XY: 632226
GnomAD4 exome
AF:
AC:
83934
AN:
1248062
Hom.:
Cov.:
19
AF XY:
AC XY:
42064
AN XY:
632226
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0504 AC: 7665AN: 152166Hom.: 277 Cov.: 32 AF XY: 0.0509 AC XY: 3789AN XY: 74372
GnomAD4 genome
AF:
AC:
7665
AN:
152166
Hom.:
Cov.:
32
AF XY:
AC XY:
3789
AN XY:
74372
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
47
AN:
3476
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 20, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at